Olezarsen Cuts Triglycerides, Reduces Pancreatitis Risk – Medscape

1. Olezarsen Cuts Triglycerides, Reduces Pancreatitis Risk  Medscape
2. New Drug Demonstrates Major Triglyceride Reductions and Liver Fat Improvements in Phase 2 Trial  Pharmacy Times
3. Physician Views Preview: Can Tryngolza break out of its rare disease niche?  FirstWord Pharma
4. Promising Potential of Ionis Pharmaceuticals’ Olezarsen Drives Buy Rating  TipRanks
5. Ionis’ Tryngolza ‘Game-Changing in Lowering Triglycerides, Cementing Case for FDA Filing  BioSpace

Continue Reading